Dergiler / Medicine Science / 2016 / Cilt: 5 - Sayı: 4

Primary pure ependymoma: a rare entity of the ovary

Sayfa
1021–1023
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

To establish standard treatment modalities for neuroectodermal tumors of the ovary, it is essential to discuss all cases of ovarian epenymoma in the literature

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Ependymomas are an uncommon glial tumors that usually arise from the central nervous system but they can occasionally occur in various extra-axial regions.
📊
Temel Bulgular & Veri:Pure ovarian ependymoma, classified as differentiated glioma, was first described by Kleinman et al in 1984 and only a few cases have been reported since then.
💡
Sonuç & Katkı:To establish standard treatment modalities for neuroectodermal tumors of the ovary, it is essential to discuss all cases of ovarian epenymoma in the literature
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Ependymomas are an uncommon glial tumors that usually arise from the central nervous system but they can occasionally occur in various extra-axial regions. Pure ovarian ependymoma, classified as differentiated glioma, was first described by Kleinman et al in 1984 and only a few cases have been reported since then. A 48 year-old multiparous woman with the diagnosis of left adnexal mass underwent surgery. Macroscopic evaluation of the left ovary showed 11x8 cm sized smooth-walled mass. Microscopic examination revealed small to medium sized cells with hyperchromatic, round to oval nuclei and scanty cytoplasm, perivascular pseudorosettes. Immunohistochemical staining for GFAP, vimentin, estrogen and progesterone receptors were positive. Based on these histopathologic and immunohistochemical features, the tumor was diagnosed as an ovarian ependymoma. As they seem rare, there is no verified treatment modality for ovarian ependymomas. , it is important to report these rare tumors, to shed light to the management and followup of them. To establish standard treatment modalities for neuroectodermal tumors of the ovary, it is essential to discuss all cases of ovarian epenymoma in the literature

🔖

Bu Makaleye Atıf Yap

AYDOĞMUŞ, H., YALCİN, S. E., AYDOĞMUŞ, S., GENÇDAL, S., ÇALLI, A. O., KELEKÇİ, S. (2016). Primary pure ependymoma: a rare entity of the ovary. Medicine Science, Cilt: 5 - Sayı: 4, 1021–1023. https://ajindex.com/articles/277707

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (9)

  1. Stolnicu S, Furtado A, Sanches A, Nicolae A, Preda O, Hincu M, Nogales FF. Ovarian ependymomas of extra-axial type or central immunophenotypes. Hum Pathol. 2011;42(3):403-8.
  2. Kleinman GM, Young RH, Scully RE. Primary neuroectodermal tumors of the ovary. A report of 25 cases. Hum Pathol.;15(8):632-8.
  3. Morovic A, Damjanov I. Neuroectodermal ovarian tumors: a brief overview. Histol Histopathol. 2008;23(6):765-71.
  4. Hirahara F, Yamanaka M, Miyagia E, Nakazawa T, Gorai I, Minaguchi H, Kakei M, Yamamoto M, Kitamura H. Pure ovarian ependymoma: report of a case treated with surgery, chemotherapy, irradiation and hyperthermotherapy. Eur J Obstet Gynecol Reprod Biol. 1997;75(2):221-3.
  5. Garcia-Barriola V, De Gómez MN, Suárez JA, Lara C, González JE, García-Tamayo J. Ovarian ependymoma. A case report. Pathol Res Pract. 2000;196(8):595-9.
  6. Carr KA, Roberts JA, Frank TS. Progesterone receptors in bilateral ovarian ependymoma presenting in pregnancy. Hum Pathol.;23(8):962-5.
  7. Erdoğan G, Ozel E, Peştereli HE, Salar Z, Tirak B, Karaveli S. Ovarian ependymoma. APMIS 2005;113(4):301-3.
  8. Auerbach R, Mittal K, Schwartz PE. Estrogen and progestin receptors in an ovarian ependymoma. Obstet Gynecol. 1988;71(6 Pt 2):1043-5.
  9. Guerrieri C, Jarlsfelt I. Ependymoma of the ovary. A case report with immunohistochemical, ultrastructural, and DNA cytometric findings, as well as histogenetic considerations. Am J Surg Pathol.;17(1):623-32.